Experts call for better cancer tests to tailor treatment 30 Jan 2023 Greater use of cancer tests is the key to tailoring use of new treatments for patients more precisely and so increasing their chances of being recommended for use within the NHS, experts say. Find out more Show/Hide
New targeted drug shows benefit against breast cancer in first phase III trial 08 Dec 2022 A new type of targeted medicine has shown ‘remarkable’ benefits for patients with advanced breast cancer in a major phase III clinical trial. Find out more Show/Hide
ICR welcomes MHRA approval of 'search and destroy' prostate cancer treatment 11 Aug 2022 The Institute of Cancer Research, London, strongly welcomes the news that 177Lu-PSMA-617, a highly targeted radioactive drug, has been approved by the medicines regulator, the MHRA, for some patients with advanced prostate cancer. Find out more Show/Hide
All patients’ cancers should be genetically profiled to improve care, say leading health experts 08 Aug 2022